The average one-year price target for Standard BioTools (NasdaqGS:LAB) has been revised to $1.58 / share. This is a decrease ...

On November 18, the entities bought 275,000 shares. The next day, November 19, they acquired 350,000 shares. On November 20, they purchased an additional 450,000 shares. These purchases come at a time ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But the last three years have been particularly tough on longer term Standard ...

Casdin Partners, a significant shareholder in Standard BioTools Inc (NASDAQ:LAB), has recently increased its stake in the company. Between November 13 and November 17, 2025, Casdin purchased a total ...

Revenue estimates for Standard BioTools Inc (NASDAQ:LAB) have remained steady at $171.20 million for the full year 2024. However, they have declined from $188.17 million to $186.93 million for 2025 ...

UMC has received a lab certificate accredited by the College of American Pathologists, a program that focuses on continuous improvement, patient care and safety. They are recognized as the gold ...